S&P 500 Hits Another New All-Time High Zacks - Tue Apr 13, 5:20PM CDT Mark Vickery - ZACKS - Tue Apr 13, 5:20PM CDT
The index's totals weren't super-noteworthy in the daily performance, +0.33%, but this April has seen multiple new highs four of the past six sessions.
Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study Zacks - Tue Apr 13, 4:27PM CDT Zacks Equity Research - ZACKS - Tue Apr 13, 4:27PM CDT
Sage (SAGE) and partner Biogen (BIIB) announce positive top-line results from the phase II, placebo-controlled KINETIC study in patients with essential tremor.
Myovant (MYOV), Pfizer Start Dosing in Relugolix Combo Study Zacks - Tue Apr 13, 4:24PM CDT Zacks Equity Research - ZACKS - Tue Apr 13, 4:24PM CDT
Myovant (MYOV) and Pfizer (PFE) initiate dosing in the phase III SERENE study evaluating the contraceptive efficacy of the relugolix combination tablet.
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day BusinessWire - Tue Apr 13, 3:29PM CDT CMTX - Tue Apr 13, 3:29PM CDT
--Antibody persistence data out to 6 months published in The New England Journal of Medicine
Consumer Price Index Rise 0.6% Zacks - Tue Apr 13, 9:42AM CDT Zacks Equity Research - ZACKS - Tue Apr 13, 9:42AM CDT
Consumer Price Index Rise 0.6%
CPI +0.6%: Higher, but Not Scary; JNJ Vax on Hold? Zacks - Tue Apr 13, 9:28AM CDT Mark Vickery - ZACKS - Tue Apr 13, 9:28AM CDT
Headline CPI last month reached +0.6%, 10 basis points ahead of consensus, and the highest single-month tally since June of 2009.
Thinking about trading options or stock in Moderna, BioNTech, AstraZeneca, Overstock.com, or GrubHub? PR Newswire - PRF - Tue Apr 13, 8:31AM CDT CMTX - Tue Apr 13, 8:31AM CDT
, /PRNewswire/ --Â InvestorsObserver issues critical PriceWatch Alerts for MRNA, BNTX, AZN, OSTK, and GRUB.
Bristol Myers' (BMY) Opdivo Combo Encouraging in NSCLC study Zacks - Mon Apr 12, 2:40PM CDT Zacks Equity Research - ZACKS - Mon Apr 12, 2:40PM CDT
Bristol Myers Squibb (BMY) announces positive results from a late-stage study evaluating Opdivo plus chemotherapy for resectable NSCLC.
Has Moderna (MRNA) Outpaced Other Medical Stocks This Year? Zacks - Mon Apr 12, 10:30AM CDT Zacks Equity Research - ZACKS - Mon Apr 12, 10:30AM CDT
Is (MRNA) Outperforming Other Medical Stocks This Year?
Stock Market News for Apr 12, 2021 Zacks - Mon Apr 12, 8:33AM CDT Zacks Equity Research - ZACKS - Mon Apr 12, 8:33AM CDT
Benchmarks hit record levels on Friday, closing in the green for consecutive weeks as investors shrugged off inflation fears and focused on quarterly earnings season amid reopening optimism
GOOGL : 2,254.43 (+0.44%) J&J's (JNJ) COVID-19 Jab Under EU Review for Rare Blood Clots Zacks - Mon Apr 12, 6:05AM CDT Zacks Equity Research - ZACKS - Mon Apr 12, 6:05AM CDT
The European drug regulator's safety committee is conducting a review to asses a link between J&J's (JNJ) COVID-19 vaccine and rare blood clots.
Bristol Myers' (BMY) Opdivo Combo Positive in ESCC Study Zacks - Fri Apr 9, 3:20PM CDT Zacks Equity Research - ZACKS - Fri Apr 9, 3:20PM CDT
Bristol Myers (BMY) announces encouraging data from the late-stage study evaluating Opdivo plus chemotherapy and Opdivo plus Yervoy in ESCC study.
ImmunityBio (IBRX) Reports Positive COVID-19 Vaccine Data Zacks - Fri Apr 9, 3:18PM CDT Zacks Equity Research - ZACKS - Fri Apr 9, 3:18PM CDT
ImmunityBio (IBRX) reports positive initial data on its COVID-19 vaccine candidate in healthy phase I study participants.
Merck (MRK) Keytruda Meets Endpoint in Kidney Cancer Study Zacks - Fri Apr 9, 9:57AM CDT Zacks Equity Research - ZACKS - Fri Apr 9, 9:57AM CDT
Merck (MRK) is developing a Keytruda monotherapy regimen for adjuvant treatment of renal cell carcinoma patients.
Higher-Than-Expected PPI in March Zacks - Fri Apr 9, 9:57AM CDT Zacks Equity Research - ZACKS - Fri Apr 9, 9:57AM CDT
Higher-Than-Expected PPI in March.
PPI Doubles Month Over Month to 1.0% Zacks - Fri Apr 9, 9:36AM CDT Mark Vickery - ZACKS - Fri Apr 9, 9:36AM CDT
We haven't seen a higher headline PPI figure since the fallout of the pandemic era, now more than a year ago.
Lilly's (LLY) JAK Inhibitor Olumiant Fails COVID-19 Study Zacks - Fri Apr 9, 8:55AM CDT Zacks Equity Research - ZACKS - Fri Apr 9, 8:55AM CDT
Lilly (LLY) and Incyte's Olumiant (baricitinib) in combination standard of care fails in a late-stage study evaluating it in hospitalized COVID-19 patients.
Moderna to Present at the 20th Annual Needham Virtual Healthcare Conference BusinessWire - Fri Apr 9, 7:00AM CDT CMTX - Fri Apr 9, 7:00AM CDT
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that David Meline, Chief Financial Officer, and Lavina Talukdar, Senior...
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus Zacks - Thu Apr 8, 4:00PM CDT Sweta Jaiswal, Frm - ZACKS - Thu Apr 8, 4:00PM CDT
Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.
AstraZeneca (AZN) COVID-19 Jab May Have Link to Rare Blood Clots Zacks - Thu Apr 8, 8:23AM CDT Zacks Equity Research - ZACKS - Thu Apr 8, 8:23AM CDT
European regulators find a possible link between AstraZeneca's (AZN) COVID-19 vaccine and rare blood clot events.
